EDIL3 and cancer: In total, nine inflammation and cancer-associated DEGs were selected to show their changed expression patterns, comprising four up-DEGs (ADM, FSTL3, SPDEF, and SPNS2) and five down-DEGs (TACSTD2, CCL2, EDIL3, FAM20C, and OLFML2A).